BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Contract Manufacturing

WuXi AppTec Breaks Ground on New R&D and Manufacturing Site in Singapore

WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life scie...

May 24, 2024 | News

AGC Biologics Completes Production of VAR2 Pharmaceuticals' Cancer-Targeting Antibodies

AGC Biologics announced the completion of work with VAR2 Pharmaceuticals on the production of the company’s two antibody candidates targeti...

April 25, 2024 | News

Samsung Biologics Reports Robust Growth in First Quarter of 2024, Revenue Surges by 31.3%

Recorded Q1'24 consolidated revenue of KRW 946.9 billion Recorded Q1'24 consolidated operating profit of KRW 221.3 billion Sustained growth d...

April 25, 2024 | News

AGC Biologics Expands in Yokohama with Advanced Biomanufacturing Hub Featuring Cytiva Technology

New AGC Biologics facility in Yokohama strengthens access to world-class biomanufacturing in Japan, offering mammalian, mRNA and cell therapy ser...

April 23, 2024 | News

Invenra and Catalent Forge Partnership to Advance Cancer Treatment Innovations

Invenra Inc., an innovative leader in bispecific antibody technology, is pleased to announce a strategic collaboration with Catalent, a global Contract Dev...

April 03, 2024 | News

Bespak Completes Separation from Recipharm,Shifts Focus to Low GWP Inhalers

Bespak announced the completion of the transaction to separate Recipharm’s former Advanced Delivery Systems Business Unit from the Recipharm Gr...

April 02, 2024 | News

Aragen Biologics Launches First Phase of New Facility in India, Spearheading Novel Anticancer mAb Manufacturing

Aragen, a leading Contract Research Development and Manufacturing Organization (CRDMO) for small molecules and biologics, announced that it has operat...

March 28, 2024 | News

WuXi Biologics Breaks Ground on State-of-the-Art $1.4 Billion CRDMO Facility in Singapore

WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced ...

March 19, 2024 | News

Ajinomoto Bio-Pharma Services Sweeps CDMO Leadership Awards in Unprecedented Six-Category Win

Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, received CDMO Le...

March 13, 2024 | News

SK bioscience and Sanofi to Boost Global Vaccine Supply with Major Expansion of L HOUSE Manufacturing Plant

The company will expand its manufacturing plant, L HOUSE, with additional cGMP-level facility. The new space will serve as a production base for the pne...

March 08, 2024 | News

Suven Pharmaceuticals Joins Forces with Cohance Lifesciences in Transformative Merger to Strengthen CDMO Dominance

Transformative Merger with 2x Scale and Double-Digit EPS Accretion in the first year Suven poised to become a leading integrated CDMO player...

March 01, 2024 | News

BioCina and NovaCina Join Forces for Integrated Biologics Solutions

BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), and NovaCina Pty Ltd., a global fill-and-finish...

February 28, 2024 | News

GC Cell and BioCentriq® Execute Process Transfer Agreement in Anticipation of the U.S. entry of Immuncell-LC Inj

Immuncell-LC Inj. is an autologous Cytokine Induced Killer (CIK) cell therapy approved for Commercial use in South Korea as an adjuvant cell th...

February 27, 2024 | News

Charles River and Wheeler Bio Forge Strategic Alliance to Streamline Drug Development Process

This partnership aims to enhance therapeutic discovery and expedite the journey to Investigational New Drug (IND) submission by combining Charles R...

February 23, 2024 | News

Stay Connected